tirzepatide decision today Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro tirzepatide court UPDATE [March 7,

In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023

Enhanced paid the athletes salaries, and each winner would get a quarter-million-dollar bonus

Follow your SOP and the SDS for stability, container choice, and holding time

If you experience symptoms such as increased anxiety, feelings of depression, or noticeable changes in your mental health, contact your provider immediately

Milliliters (mL) measure the volume of liquid you draw into the syringe